{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:42:01Z","timestamp":1782963721625,"version":"3.54.5"},"reference-count":14,"publisher":"National Center for Global Health and Medicine (JST)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM"],"published-print":{"date-parts":[[2021,10,31]]},"DOI":"10.35772\/ghm.2021.01057","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T22:11:55Z","timestamp":1634335915000},"page":"288-292","source":"Crossref","is-referenced-by-count":4,"title":["Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea"],"prefix":"10.35772","volume":"3","author":[{"given":"Youngmee","family":"Jee","sequence":"first","affiliation":[{"name":"Institut Pasteur Korea, Gyunggi-do, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21485","reference":[{"key":"1","unstructured":"1. World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016-2021. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf;jsessionid=9A17B3F9C66A7A152BD4D5368FBB2524?sequence=1<\/i> (accessed May 16, 2021)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pedrana A, Howell J, Scott N, et al<\/i>. Global hepatitis C elimination: an investment framework. Lancet Gastroenterol Hepatol. 2020; 5:927-939.","DOI":"10.1016\/S2468-1253(20)30010-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dore GJ, Bajis S. Hepatitis C virus elimination: laying the foundation for achieving 2030 targets. Nat Rev Gastroenterol Hepatol. 2021; 18:91-92.","DOI":"10.1038\/s41575-020-00392-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Waked I, Esmat G, Elsharkawy A, et al<\/i>. Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med. 2020; 382:1166-1174.","DOI":"10.1056\/NEJMsr1912628"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Radley A, de Bruin M, Inglis SK, Donnan PT, Hapca A, Barclay ST, Fraser A, Dillon JF. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. Lancet Gasteroenterol Hepatol. 2020; 5:809-818.","DOI":"10.1016\/S2468-1253(20)30120-5"},{"key":"6","unstructured":"6. Ministry of Health and Welfare of the Republic of Korea. Press Release "Launching a pilot study on early detection of hepatitis C cases" http:\/\/www.mohw.go.kr\/react\/al\/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=1&CONT_SEQ=359673<\/i> (accessed May 16, 2021). (in Korean)"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jeong SH, Jang ES, Choi HY, Kim KA, Chung W, Ki M. Current status of hepatitis C virus infection and countermeasures in South Korea. Epidemiol Health. 2017; 39: e2017017.","DOI":"10.4178\/epih.e2017017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chung YS, Choi JY, Han MG, Park KR, Park SJ, Lee H, Jee Y, Kang C. A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea. J Clin Virol. 2018; 106:53-57.","DOI":"10.1016\/j.jcv.2018.07.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C diagnosis: simplified solutions, predictive barriers, and future promises. Diagnostics (Basel). 2021; 11:1253.","DOI":"10.3390\/diagnostics11071253"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tatara E, Gutfraind A, Collier NT, Echevarria D, Cotler SJ, Major M, Ozik J, Dahari H, Boodram B. Re-treatment with direct-acting antivirals policy is needed to eliminate Hepatitis C among persons who inject drugs. bioRxiv. 2021. doi: https:\/\/doi.org\/10.1101\/653196.","DOI":"10.1101\/653196"},{"key":"11","unstructured":"11. 2020 National Hepatitis C Control Guideline by KDCA. http:\/\/www.kdca.go.kr\/npt\/biz\/npp\/portal\/nppPblctDtaView.do?pblctDtaSeAt=8&pblctDtaSn=2081<\/i> (accessed May 16, 2021). (in Korean)"},{"key":"12","unstructured":"12. Kim Y. Current status and countermeasures for hepatitis B and D in Korea. https:\/\/www.kasl.org\/pdf\/2016_fall\/%ea%b9%80%ec%9c%a4%ec%a4%802.pdf<\/i> (assessed May 16, 2021). (in Korean)"},{"key":"13","unstructured":"13. Korean Association for the Study of the Liver. Press release "Elimination of hepatitis C by 2030". https:\/\/www<\/i>.<\/i>kasl.org\/bbs\/index.html?code=report&category=&gubun=&page=1&number=4207&mode=view&keyfield=&k ey=<\/i> (assessed May 16, 2021)."},{"key":"14","unstructured":"14. Infectious Disease Portal. Korea Disease Control Agency. http:\/\/www.kdca.go.kr\/npt\/biz\/npp\/ist\/bass\/bassDissStatsMain.do<\/i> (assessed May 16, 2021)."}],"container-title":["Global Health & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/3\/5\/3_2021.01057\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T03:41:41Z","timestamp":1636774901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/3\/5\/3_2021.01057\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.35772\/ghm.2021.01057","relation":{},"ISSN":["2434-9186","2434-9194"],"issn-type":[{"value":"2434-9186","type":"print"},{"value":"2434-9194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"article-number":"2021.01057"}}